Yifan Xinfu Pharmaceutical Co Ltd (002019) — Cash Flow Reinvestment Rate
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Cash Flow Reinvestment Rate of 4.60x as of September 2025, reinvesting CN¥184.68 Million (capex CN¥184.68 Million ) from operating cash flow of CN¥40.18 Million. See 002019 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Yifan Xinfu Pharmaceutical Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see 002019 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Yifan Xinfu Pharmaceutical Co Ltd. See Yifan Xinfu Pharmaceutical Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | CN¥639.96 Million | CN¥458.37 Million | CN¥559.23 Million | ▲ +26.7% |
| 2024 | 1.10x | CN¥705.83 Million | CN¥640.73 Million | CN¥628.16 Million | ▼ -63.0% |
| 2023 | 2.97x | CN¥1.04 Billion | CN¥348.58 Million | CN¥504.09 Million | ▲ +15.8% |
| 2022 | 2.57x | CN¥1.21 Billion | CN¥472.07 Million | CN¥542.27 Million | ▲ +21.2% |
| 2021 | 2.12x | CN¥638.34 Million | CN¥301.23 Million | CN¥571.74 Million | ▲ +216.7% |
| 2020 | 0.67x | CN¥741.71 Million | CN¥1.11 Billion | CN¥715.71 Million | ▼ -34.2% |
| 2019 | 1.02x | CN¥952.57 Million | CN¥937.24 Million | CN¥866.07 Million | ▼ -7.3% |
| 2018 | 1.10x | CN¥1.28 Billion | CN¥1.17 Billion | CN¥729.21 Million | ▲ +17.4% |
| 2017 | 0.93x | CN¥1.06 Billion | CN¥1.13 Billion | CN¥485.86 Million | ▼ -39.4% |
| 2016 | 1.54x | CN¥1.32 Billion | CN¥855.85 Million | CN¥287.50 Million | ▲ +131.9% |
| 2015 | 0.66x | CN¥267.15 Million | CN¥401.96 Million | CN¥217.15 Million | ▲ +3.8% |
| 2014 | 0.64x | CN¥89.51 Million | CN¥139.74 Million | CN¥89.51 Million | ▼ -70.3% |
| 2013 | 2.15x | CN¥73.95 Million | CN¥34.32 Million | CN¥73.95 Million | ▼ -4.8% |
| 2012 | 2.26x | CN¥67.64 Million | CN¥29.88 Million | CN¥67.64 Million | ▼ -12.3% |
| 2009 | 2.58x | CN¥151.27 Million | CN¥58.61 Million | CN¥151.27 Million | ▲ +75.6% |
| 2008 | 1.47x | CN¥122.46 Million | CN¥83.31 Million | CN¥122.46 Million | ▲ +112.5% |
| 2007 | 0.69x | CN¥172.06 Million | CN¥248.71 Million | CN¥172.06 Million | ▼ -60.8% |
| 2006 | 1.77x | CN¥57.62 Million | CN¥32.62 Million | CN¥57.62 Million | ▼ -27.3% |
| 2005 | 2.43x | CN¥58.63 Million | CN¥24.12 Million | CN¥58.63 Million | ▲ +16.4% |
| 2004 | 2.09x | CN¥70.14 Million | CN¥33.59 Million | CN¥70.14 Million | ▼ -49.6% |
| 2003 | 4.14x | CN¥52.44 Million | CN¥12.65 Million | CN¥52.44 Million | — |